Stockreport

Beam Therapeutics Advances Genetic, Hematology Pipeline, Extends Cash Runway to 2029; Shares Rise [Yahoo! Finance]

Beam Therapeutics Inc.  (BEAM) 
PDF Beam Therapeutics (BEAM) said Sunday it is making continued progress across its liver-targeted genet [Read more]